Schorno Dean L's Form 4 filing
Rigel Pharmaceuticals Inc (RIGL) · filed Sep 3, 2026
- Accession no.
- 0000905148-26-004080
- Filed
- Sep 3, 2026, 7:02 PM ET
- Trade date
- Sep 1-2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schorno Dean LCIK 0001509688 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | FTax withholdingDisposed | −928 | $47.50 | −$44,080 | 78,362 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseAcquired | +694 | $12.70 | +$8,813.8 | 79,056 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseAcquired | +620 | $18.70 | +$11,594 | 79,676 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseAcquired | +2,000 | $24.20 | +$48,400 | 81,676 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseAcquired | +1,286 | $24.20 | +$31,121.2 | 82,962 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | MOption exerciseDisposed | −694 | $0.00 | $0 | 12,824 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseDisposed | −620 | $0.00 | $0 | 9,012 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 7,999 | Direct | |
| Sep 2, 2026 | Common Stock | MOption exerciseDisposed | −1,286 | $0.00 | $0 | 15,867 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.